Barry Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Barry Investment Advisors, LLC

$322 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$71.58 - $87.29 $28,918 - $35,265	-404 Reduced 12.05%	2,949 $216,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $66,455 - $75,362	-907 Reduced 21.29%	3,353 $271,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $2,883 - $3,146	-39 Reduced 0.91%	4,260 $319,000
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $90,071 - $102,739	-1,185 Reduced 21.61%	4,299 $331,000
Q1 2023 Apr 27, 2023	SELL	$77.31 - $88.08 $7,576 - $8,631	-98 Reduced 1.76%	5,484 $455,000
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $48,360 - $69,428	-776 Reduced 12.21%	5,582 $0
Q3 2022 Oct 24, 2022	SELL	$59.54 - $68.01 $54,776 - $62,569	-920 Reduced 12.64%	6,358 $392,000
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $48,946 - $55,128	-848 Reduced 10.44%	7,278 $450,000
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $38,980 - $48,846	-673 Reduced 7.65%	8,126 $483,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $16,868 - $19,146	-260 Reduced 2.87%	8,799 $639,000
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $44,946 - $48,491	-664 Reduced 6.83%	9,059 $633,000
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $8,695 - $9,500	-137 Reduced 1.39%	9,723 $669,000
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $1,920 - $2,190	32 Added 0.33%	9,860 $637,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $17,334 - $19,752	-306 Reduced 3.02%	9,828 $573,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $31,981 - $40,211	-515 Reduced 4.84%	10,134 $640,000
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $72,195 - $83,832	-998 Reduced 8.57%	10,649 $819,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $64,446 - $82,546	1,029 Added 9.69%	11,647 $871,000
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $49,296 - $54,224	800 Added 8.15%	10,618 $683,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $30,067 - $33,189	-481 Reduced 4.67%	9,818 $622,000
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $4,763 - $5,342	77 Added 0.75%	10,299 $696,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $35,642 - $39,928	570 Added 5.91%	10,222 $665,000
Q4 2018 Jan 28, 2019	BUY	$60.54 - $79.0 $8,778 - $11,455	145 Added 1.53%	9,652 $604,000
Q3 2018 Oct 19, 2018	BUY	$71.28 - $78.92 $6,201 - $6,866	87 Added 0.92%	9,507 $734,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $99,396 - $115,941	-1,532 Reduced 13.99%	9,420 $667,000
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $98,334 - $119,880	1,350 Added 14.06%	10,952 $826,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $138,884 - $163,031	1,952 Added 25.52%	9,602 $688,000
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $551,641 - $653,845	7,650	7,650 $620,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barry Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barry Investment Advisors, LLC with notifications on news.

Account